Under US law, compounding pharmacies can make and sell patent-protected drugs that are on the FDA's shortages list in limited amounts, and have been reaping the rewards of supplying versions of Novo Nordisk's obesity drug Wegovy and Ozempic for diabetes, which are both based on the GLP-1 receptor agonist
When comparisons were made with other oral drugs used in type 2 diabetes, the reductions in HbA 1c were comparable with glitazones, but slightly less than with metformin or sulphonylureas
Your success in maintenance often correlates with the habits you built throughout your GLP-1 journey
See our full FAQ page for 25+ questions
If the question is about repeated signaling, split administration may make more sense than a one-time daily exposure
IV Nutrition Replenish, revive, refuel, restore and revitalize from the inside out Book An Appointment Today